acetylglucosamine has been researched along with Lysosomal Enzyme Disorders in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 30 (83.33) | 18.2507 |
2000's | 5 (13.89) | 29.6817 |
2010's | 1 (2.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvio, M; Mononen, I | 1 |
Autti, T; Joensuu, R; Lönnqvist, T | 1 |
Arvio, M; Arvio, P; Hurmerinta, K; Pirinen, S; Sillanpää, M | 1 |
Danos, O; Enomaa, N; Jalanko, A; Peltonen, L | 1 |
Aula, P; Hietala, M; Isoniemi, A; Jalanko, A; Peltonen, L | 1 |
Ankener, W; Brainerd, S; Delahunty, CM; Mononen, IT; Nickerson, DA | 1 |
Mononen, I; Mononen, T; Savolainen, K; Ylikangas, P | 1 |
Borud, O; Nilssen, O; Tollersrud, OK; Tranebjaerg, L | 2 |
Kaartinen, V; Mononen, I; Mononen, T; Savolainen, K; Ylikangas, P | 1 |
Järveläinen, HT; Määttä, A; Nelimarkka, LO; Penttinen, RP | 1 |
Ikonen, E; Peltonen, L; Syvänen, AC | 1 |
Arvio, M; Autio, S; Gaily, E; Oksanen, V; Sainio, K | 1 |
Aronson, NN; Fisher, KJ; Kaartinen, V; Mononen, I | 1 |
Arvio, M | 1 |
Aronson, NN; Fensom, AH; Park, H; Rossiter, M; Winchester, B | 1 |
Gonzalez-Gomez, I; Groffen, J; Heisterkamp, N; Kaartinen, V; Mononen, I; Noronkoski, T; Voncken, JW | 1 |
Aula, P; Greenberg, CR; Haworth, JC; Hietala, M; Laitinen, A; Schroeder, ML; Seargeant, LE | 1 |
Aronen, HJ; Autti, T; Haltia, M; Lauronen, L; Raininko, R; Salonen, O; Santavuori, P; Vanhanen, SL; Wirtavuori, K | 1 |
Autti, T; Ginns, EI; Ikonen, S; Jalanko, A; Joensuu, R; LaMarca, ME; Manninen, T; McKinney, CE; Peltonen, L; Rapola, J; Riekkinen, P; Sipilä, I; Tenhunen, K | 1 |
Coulter-Mackie, MB; Gordon, BA; Haust, MD; Hinton, GG; Rip, JW; Rupar, CA; Scott, E | 1 |
Arvio, MA; Pelkonen, PM; Rapola, JM | 1 |
Yamaguchi, S | 1 |
Gonzalez-Gomez, I; Groffen, J; Heisterkamp, N; Kaartinen, V; Mononen, I; Noronkoski, T | 1 |
Gonzalez-Gomez, I; Groffen, J; Heisterkamp, N; Kaartinen, V; Mononen, I | 1 |
Arvio, M; Arvio, P; Lukinmaa, PL; Pirinen, S; Saxen, L; Wolf, J | 1 |
Arvio, M; Arvio, P; Kero, M; Lukinmaa, PL; Pirinen, S | 1 |
Arvio, M; Arvio, P; Marttinen, E; Pirinen, S; Sipilä, I | 1 |
Fahlman, C; Jalanko, A; Karlsson, S; Laine, M; Peltonen, L; Rapola, J; Renlund, M; Richter, J | 1 |
Aronson, NN | 1 |
Dunder, U; Groffen, J; Heisterkamp, N; Kaartinen, V; Kosma, VM; Mononen, I; Väänänen, E; Valtonen, P | 1 |
Aula, P; Hietala, M; Savontaus, ML; Valkonen, S | 1 |
Cooper, A; Forsyth, JM; Guy, R; Morton, RE | 1 |
Dunder, U; Mononen, I | 1 |
Ikonen, E; Peltonen, L | 1 |
Aula, P; Bengtström, M; Ikonen, E; Manninen, T; Peltonen, L; Söderlund, H; Syvänen, AC | 1 |
6 review(s) available for acetylglucosamine and Lysosomal Enzyme Disorders
Article | Year |
---|---|
Aspartylglycosaminuria: a review.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Glycoproteins; Humans; Lysosomal Storage Diseases; Mutation | 2016 |
Dissection of the molecular pathology of aspartylglucosaminuria provides the basis for DNA diagnostics and future therapeutic interventions.
Topics: Acetylglucosamine; Aspartylglucosaminuria; Aspartylglucosylaminase; DNA; Finland; Humans; Lysosomal Storage Diseases; Mutation | 1993 |
Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation.
Topics: Acetylglucosamine; Amino Acid Sequence; Aminolevulinic Acid; Animals; Aspartylglucosylaminase; Base Sequence; Biological Evolution; Carbohydrate Sequence; DNA, Complementary; Glycoproteins; Humans; Lysosomal Storage Diseases; Molecular Sequence Data; Mutation | 1993 |
[Aspartylglucosaminuria].
Topics: Acetylglucosamine; Aspartylglucosaminuria; Aspartylglucosylaminase; Biomarkers; Diagnosis, Differential; Humans; Lysosomal Storage Diseases; Prognosis | 1998 |
Aspartylglycosaminuria: biochemistry and molecular biology.
Topics: Acetylglucosamine; Amino Acid Sequence; Animals; Aspartylglucosylaminase; Base Sequence; Disease Models, Animal; DNA, Complementary; Evolution, Molecular; Finland; Gene Deletion; Gene Rearrangement; Glycoproteins; Humans; Lysosomal Storage Diseases; Lysosomes; Molecular Sequence Data; Mutation; Mutation, Missense | 1999 |
Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
Topics: Acetylglucosamine; Amino Acid Sequence; Aspartylglucosaminuria; Aspartylglucosylaminase; Base Sequence; DNA; DNA Mutational Analysis; Finland; Gene Frequency; Genetic Carrier Screening; Humans; Lysosomal Storage Diseases; Molecular Structure; Phenotype | 1992 |
30 other study(ies) available for acetylglucosamine and Lysosomal Enzyme Disorders
Article | Year |
---|---|
Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Imaging, Three-Dimensional; Lysosomal Storage Diseases; Magnetic Resonance Imaging; Male; Pulvinar; Retrospective Studies; Thalamus | 2008 |
Reduction in head size in patients with aspartylglucosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Aged; Aspartylglucosaminuria; Aspartylglucosylaminase; Cephalometry; Child; Child, Preschool; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Lysosomal Storage Diseases; Male; Microcephaly; Reference Values | 2005 |
Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Base Sequence; Cell Line; CHO Cells; Cricetinae; DNA Primers; Endocytosis; Feasibility Studies; Gene Transfer Techniques; Genetic Therapy; Humans; Lysosomal Storage Diseases; Molecular Sequence Data; Neurons; Recombinant Proteins; Retroviridae | 1995 |
Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene.
Topics: Acetylglucosamine; Amino Acid Sequence; Aspartylglucosaminuria; Aspartylglucosylaminase; Base Sequence; Chromosome Mapping; DNA Mutational Analysis; Exons; Female; Finland; Humans; Lysosomal Storage Diseases; Male; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Sequence Deletion | 1995 |
Finnish-type aspartylglucosaminuria detected by oligonucleotide ligation assay.
Topics: Acetylglucosamine; Alleles; Aspartylglucosaminuria; Base Sequence; DNA Ligases; Finland; Heterozygote; Homozygote; Humans; Lysosomal Storage Diseases; Molecular Sequence Data; Mutation; Oligonucleotides; Polymerase Chain Reaction; Templates, Genetic | 1995 |
Neonatal detection of aspartylglycosaminuria.
Topics: Acetylglucosamine; Aspartylglucosylaminase; Female; Fetal Blood; Finland; Humans; Infant, Newborn; Lysosomal Storage Diseases; Mass Screening | 1994 |
Aspartylglucosaminuria in northern Norway: a molecular and genealogical study.
Topics: Acetylglucosamine; Adult; Aspartylglucosaminuria; Aspartylglucosylaminase; Base Sequence; DNA Primers; Female; Finland; Genes, Recessive; Humans; Lysosomal Storage Diseases; Male; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Norway; Pedigree; Point Mutation; Polymorphism, Genetic; White People | 1994 |
Enzymatic diagnosis of aspartylglycosaminuria by fluorometric assay of glycosylasparaginase in serum, plasma, or lymphocytes.
Topics: Acetylglucosamine; Adolescent; Adult; Aged; Aspartylglucosylaminase; Child; Chromatography, High Pressure Liquid; DNA; Finland; Fluorometry; Humans; Hydrogen-Ion Concentration; Lymphocytes; Lysosomal Storage Diseases; Middle Aged; Mutation; Polymerase Chain Reaction; Reference Values | 1994 |
Fibroblast expression of collagens and proteoglycans is altered in aspartylglucosaminuria, a lysosomal storage disease.
Topics: Acetylglucosamine; Aspartylglucosaminuria; Cells, Cultured; Collagen; Extracellular Matrix; Fibroblasts; Humans; Lysosomal Storage Diseases; Procollagen; Proteoglycans; RNA, Messenger; Skin; Sulfur Radioisotopes | 1994 |
Epileptic seizures in aspartylglucosaminuria: a common disorder.
Topics: Acetylglucosamine; Adolescent; Adult; Anticonvulsants; Cerebral Cortex; Child; Chromosome Aberrations; Chromosome Disorders; Dose-Response Relationship, Drug; Electroencephalography; Epilepsies, Partial; Evoked Potentials; Female; Follow-Up Studies; Genes, Recessive; Humans; Lysosomal Storage Diseases; Male; Middle Aged; Neuropsychological Tests | 1993 |
A simple and rapid PCR based method for AGU(Fin) determination.
Topics: Acetylglucosamine; Base Sequence; DNA; Female; Finland; Humans; Lysosomal Storage Diseases; Male; Molecular Sequence Data; Pedigree; Point Mutation; Polymerase Chain Reaction | 1993 |
Follow-up in patients with aspartylglucosaminuria. Part I. The course of intellectual functions.
Topics: Acetylglucosamine; Adolescent; Adult; Aspartylglucosaminuria; Case-Control Studies; Child; Child Development; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Intellectual Disability; Intelligence Tests; Lysosomal Storage Diseases; Male; Middle Aged | 1993 |
Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin.
Topics: Acetylglucosamine; Adolescent; Amino Acid Sequence; Aspartylglucosylaminase; Base Sequence; Blotting, Western; Exons; Humans; Lysosomal Storage Diseases; Male; Mauritania; Molecular Sequence Data; Polymerase Chain Reaction; Protein Processing, Post-Translational | 1996 |
A mouse model for the human lysosomal disease aspartylglycosaminuria.
Topics: Acetylglucosamine; Age Factors; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Central Nervous System; Disease Models, Animal; Female; Humans; Lysosomal Storage Diseases; Lysosomes; Male; Mice; Mice, Knockout; Psychomotor Performance; RNA, Messenger; Stem Cells; Urinary Bladder | 1996 |
Two novel mutations in a Canadian family with aspartylglucosaminuria and early outcome post bone marrow transplantation.
Topics: Acetylglucosamine; Aspartylglucosaminuria; Aspartylglucosylaminase; Bone Marrow Transplantation; Canada; Female; Humans; Infant, Newborn; Lysosomal Storage Diseases; Pedigree; Point Mutation; Sequence Analysis, DNA | 1997 |
Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation.
Topics: Acetylglucosamine; Adolescent; Adult; Age Factors; Aspartylglucosaminuria; Basal Ganglia; Brain; Case-Control Studies; Cerebral Cortex; Child; Child, Preschool; Female; Humans; Infant; Intellectual Disability; Lysosomal Storage Diseases; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Neurons; Thalamus; Vacuoles | 1997 |
Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Brain; Disease Models, Animal; Disease Progression; Gene Targeting; Genes, Recessive; Humans; Intellectual Disability; Liver; Lysosomal Storage Diseases; Magnetic Resonance Imaging; Maze Learning; Mice; Mice, Knockout; Microscopy, Electron; Phenotype | 1998 |
Aspartylglucosaminuria in a Canadian family.
Topics: Acetylglucosamine; Adult; Aspartylglucosaminuria; Aspartylglucosylaminase; Canada; Child; Female; Humans; Lysosomal Storage Diseases; Male; Middle Aged; Pedigree | 1998 |
Chronic arthritis in patients with aspartylglucosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Arthritis; Aspartylglucosaminuria; Aspartylglucosylaminase; Child; Child, Preschool; Chronic Disease; Female; Finland; Hand; Humans; Lysosomal Storage Diseases; Lysosomes; Male; Radiography; Rheumatoid Factor; Stromal Cells; Synovial Membrane; Wrist; Wrist Joint | 1998 |
Phenotypic characterization of mice with targeted disruption of glycosylasparaginase gene: a mouse model for aspartylglycosaminuria.
Topics: Acetylglucosamine; Animals; Aspartylglucosylaminase; Disease Models, Animal; Gene Targeting; Lysosomal Storage Diseases; Mice; Phenotype | 1998 |
Progressive neurodegeneration in aspartylglycosaminuria mice.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Central Nervous System; Cytoplasm; Female; Gait; Glial Fibrillary Acidic Protein; Immunoenzyme Techniques; Lysosomal Storage Diseases; Lysosomes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurodegenerative Diseases; Neurons; Urinary Bladder; Vacuoles | 1998 |
Impaired oral health in patients with aspartylglucosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Aged; Alveolar Bone Loss; Aspartylglucosaminuria; Case-Control Studies; Child; Child, Preschool; Dental Caries; DMF Index; Female; Finland; Humans; Lysosomal Storage Diseases; Male; Middle Aged; Mouth Diseases; Mouth Neoplasms; Odontogenic Tumors; Oral Hygiene Index; Periodontal Diseases; Periodontal Index; Radiography; Tooth Loss | 1998 |
Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Angiofibroma; Aspartylglucosaminuria; Aspartylglucosylaminase; Child; Child, Preschool; Face; Facial Neoplasms; Fibroma; Finland; Gingiva; Humans; Immunohistochemistry; Lysosomal Storage Diseases; Middle Aged; Mouth Mucosa; Skin; Skin Neoplasms | 1999 |
Excessive infantile growth and early pubertal growth spurt: typical features in patients with aspartylglycosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Child; Child, Preschool; Female; Finland; Growth; Humans; Infant; Infant, Newborn; Lysosomal Storage Diseases; Male; Menarche; Puberty | 1999 |
Correction of peripheral lysosomal accumulation in mice with aspartylglucosaminuria by bone marrow transplantation.
Topics: Acetylglucosamine; Amino Acid Metabolism, Inborn Errors; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Bone Marrow Transplantation; Brain; Humans; Intellectual Disability; Kidney; Liver; Lysosomal Storage Diseases; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Organ Specificity; Polymerase Chain Reaction; Radiation Chimera; Specific Pathogen-Free Organisms; Spleen; Vacuoles | 1999 |
Enzyme replacement therapy in a mouse model of aspartylglycosaminuria.
Topics: Acetylglucosamine; Animals; Aspartylglucosylaminase; Half-Life; Kidney; Liver; Lysosomal Storage Diseases; Mice; Mice, Mutant Strains; Spleen; Tissue Distribution | 2000 |
Origin of Finnish mutations causing aspartylglucosaminuria.
Topics: Acetylglucosamine; Alleles; Aspartylglucosaminuria; Aspartylglucosylaminase; Female; Finland; Haplotypes; Humans; Lysosomal Storage Diseases; Male; Mutation; Pedigree | 1999 |
Co-existence of lysosomal storage diseases in a consanguineous family.
Topics: Acetylglucosamine; Asia; Child, Preschool; Consanguinity; England; Fabry Disease; Female; Heterozygote; Humans; Infant, Newborn; Lysosomal Storage Diseases; Male; Pedigree | 2001 |
Human leukocyte glycosylasparaginase: cell-to-cell transfer and properties in correction of aspartylglycosaminuria.
Topics: Acetylglucosamine; Aspartylglucosaminuria; Aspartylglucosylaminase; Cell Line, Transformed; Coculture Techniques; Culture Media, Conditioned; Endocytosis; Fibroblasts; Fluorescent Antibody Technique; Herpesvirus 4, Human; Humans; Leukocytes; Lymphocytes; Lysosomal Storage Diseases; Lysosomes; Mannosephosphates; Protein Transport; Receptor, IGF Type 2; Y Chromosome | 2001 |
Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland.
Topics: Acetylglucosamine; Alleles; Aspartylglucosylaminase; Base Sequence; DNA; Finland; Gene Frequency; Genetic Carrier Screening; Genetic Techniques; Humans; Leukocytes; Lysosomal Storage Diseases; Molecular Sequence Data; Mutation; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Prevalence | 1992 |